Minimal Residual Disease Testing Market Size, Share & Trends Report

Minimal Residual Disease Testing Market Size, Share & Trends Analysis Report By Technology (NGS, PCR), Cancer Type (Hematological Malignancy), By End-use (Hospitals), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-016-3
Number of Pages: 130
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry:Healthcare

Market Segmentation

Minimal Residual Disease Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Flow Cytometry
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- Others
Minimal Residual Disease Testing Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Haematological Malignancy
  - Leukaemia
  - Lymphoma
- Solid Tumours
Minimal Residual Disease Testing Business Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals and Speciality Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Others
Minimal Residual Disease Testing Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Screening (NGS)
    - Others
  - North America Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
    - Hematological Malignancy
      - Leukemia
      - Lymphoma
    - Solid Tumors
  - North America Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
    - Hospitals and Specialty Clinics
    - Diagnostic Laboratories
    - Academic and Research Institutes
    - Others
  - U.S.
    - U.S. Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - U.S. Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - U.S. Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Canada
    - Canada Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Canada Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Canada Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
- Europe
  - Europe Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Screening (NGS)
    - Others
  - Europe Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
    - Hematological Malignancy
      - Leukemia
      - Lymphoma
    - Solid Tumors
  - Europe Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
    - Hospitals and Specialty Clinics
    - Diagnostic Laboratories
    - Academic and Research Institutes
    - Others
  - UK
    - UK Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - UK Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - UK Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Germany
    - Germany Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Germany Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Germany Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - France
    - France Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - France Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - France Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Italy
    - 意大利微小残留病检测市场Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - 意大利微小残留病检测市场Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - 意大利微小残留病检测市场Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Spain
    - 西班牙微小残留病检测市场Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - 西班牙微小残留病检测市场Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - 西班牙微小残留病检测市场Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Denmark
    - Denmark Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Denmark Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Denmark Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Sweden
    - 瑞典微小残留病检测市场Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - 瑞典微小残留病检测市场Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - 瑞典微小残留病检测市场Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Norway
    - Norway Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Norway Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Norway Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
- Asia Pacific
  - Asia Pacific Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Screening (NGS)
    - Others
  - Asia Pacific Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
    - Hematological Malignancy
      - Leukemia
      - Lymphoma
    - Solid Tumors
  - Asia Pacific Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
    - Hospitals and Specialty Clinics
    - Diagnostic Laboratories
    - Academic and Research Institutes
    - Others
  - Japan
    - Japan Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Japan Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Japan Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - China
    - China Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - China Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - China Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - India
    - India Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - India Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - India Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Australia
    - Australia Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Australia Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Australia Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Thailand
    - Thailand Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Thailand Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Thailand Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - South Korea
    - South Korea Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - South Korea Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - South Korea Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
- Latin America
  - Latin America Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Screening (NGS)
    - Others
  - Latin America Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
    - Hematological Malignancy
      - Leukemia
      - Lymphoma
    - Solid Tumors
  - Latin America Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
    - Hospitals and Specialty Clinics
    - Diagnostic Laboratories
    - Academic and Research Institutes
    - Others
  - Brazil
    - Brazil Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Brazil Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Brazil Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Mexico
    - Mexico Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Mexico Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Mexico Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Argentina
    - Argentina Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Argentina Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Argentina Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
- MEA
  - MEA Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Screening (NGS)
    - Others
  - MEA Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
    - Hematological Malignancy
      - Leukemia
      - Lymphoma
    - Solid Tumors
  - MEA Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
    - Hospitals and Specialty Clinics
    - Diagnostic Laboratories
    - Academic and Research Institutes
    - Others
  - South Africa
    - South Africa Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - South Africa Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - South Africa Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Saudi Arabia
    - Saudi Arabia Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Saudi Arabia Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Saudi Arabia Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - UAE
    - UAE Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - UAE Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - UAE Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others
  - Kuwait
    - Kuwait Minimal Residual Disease Testing Market, By Technology 2018- 2030 (USD Million)
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Screening (NGS)
      - Others
    - Kuwait Minimal Residual Disease Testing Market, By Cancer Type, 2018- 2030 (USD Million)
      - Hematological Malignancy
        
        Leukemia
        
        Lymphoma
      - Solid Tumors
    - Kuwait Minimal Residual Disease Testing Market, By Business 2018- 2030 (USD Million)
      - Hospitals and Specialty Clinics
      - Diagnostic Laboratories
      - Academic and Research Institutes
      - Others

Report Content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s Five Forces analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.